24/7 Wall St. » CELG

Top Analyst Upgrades & Downgrades (AAPL, CELG, CLD, CNX, DRQ, EIX, NOK, PPL, LEN, PHM, TOL)

Administrator — Fri, 13 Apr 2012 12:06:55 +0000

These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Friday (Friday the 13th).

Apple Inc. (NASDAQ: AAPL) Reiterated Buy and Raised Target to $770 from $730 at BofA/ML.

Celgene Corporation (NASDAQ: CELG) Cut to Hold at Auriga.

Cloud Peak Energy Inc. (NYSE: CLD) Cut to Neutral at Credit Suisse.

CONSOL Energy Inc. (NYSE: CNX) Cut to Neutral at Credit Suisse.

Dril-Quip, Inc. (NYSE: DRQ) named as Bear of the Day at Zacks.

Edison International (NYSE: EIX) Raised to Outperform at Wells Fargo.

Nokia Corporation (NYSE: NOK) Cut to Equal-weight at Barclays.

PPL Corporation (NYSE: PPL) was maintained as Buy but removed from the Conviction Buy List at Goldman Sachs.

Lennar Corporation (NYSE: LEN), PulteGroup, Inc. (NYSE: PHM), and Toll Brothers Inc. (NYSE: TOL) were all raised to Buy from Hold at KeyBanc today.

VMware Inc. (NYSE: VMW) Started as Overweight at Piper Jaffray.

If you enjoyed the top analyst upgrades and downgrades, you can join our free email newsletter that includes analyst summaries each morning sent right to your inbox. We also cover top issues such as IPOs, special financial exclusives, mergers and more. Sign up in the box below.

JON C. OGG

Filed under: Analyst Calls Tagged: AAPL, CELG, CLD, CNX, DRQ, EIX, LEN, NOK, PHM, PPL, TOL

24/7 Wall St. Closing Bell (NSC, DNDN, EBAY, CELG, DLR, AXAS, AMCX, CATO, E, FF, ROST, TA, CLWT, TWER, AIXG, WGO, JVA, SCHL, FLML, VRS, EGLE, VRNG)

Paul Ausick — Thu, 15 Mar 2012 20:07:06 +0000

Markets opened higher this morning after positive news on new unemployment benefits claims and manufacturing (more coverage here). Indexes have risen more or less steadily all day, with the S&P set to close above 1,400 for the first time since June 2008. The US dollar index is weaker today, down -0.50% at 80.165. Most commodities rose on the dollar weakness, with the notable exception of crude oil. WTI crude oil closed down -0.3% at $105.11/barrel, and Brent crude trades down -1.52% at $122.69/barrel. Gold settled up 1% today, at $1,659.50.

The unofficial closing bells put the DJIA up about 58 points to 13,252.76 (0.44%), the NASDAQ rose more than 15 points (0.51%) to 3,056.37, and the S&P 500 rose 0.60% or more than 8 points to 1,402.59.

There were several analyst upgrades and downgrades today, including Norfolk Southern Corp. (NYSE: NSC) cut to ‘equal weight’ at Barclays; Dendreon Corp. (NASDAQ: DNDN) started as ‘hold’ at Stifel Nicolaus; Ebay Inc. (NASDAQ: EBAY) cut to ‘neutral’ at Credit Suisse; Celgene Corp. (NASDAQ: CELG) started as ‘buy’ at Stifel Nicolaus; and Digital Realty Trust (NYSE: DLR) cut to ‘hold’ at Jefferies.

Earnings reports since markets closed last night have led to some price changes as of the last half hour of trading today: Abraxas Petroleum Corp. (NASDAQ: AXAS) is down -4.6% at $3.55; AMC Networks Inc. (NASDAQ: AMCX) is down -4% at $44.18; Cato Corp. (NYSE: CATO) is down -0.2% at $27.51; ENI S.p.A. (NYSE: E) is up 1.1% at $47.89; FutureFuel Corp. (NYSE: FF) is up 1.4% at $11.53; Ross Stores Inc. (NASDAQ: ROST) is down -0.5% at $56.31; and Travelcenters of America LLC (AMEX: TA) is up 15% at $6.10.

Other standouts from today include the following stocks:

Euro Tech Holdings Co. Ltd. (NASDAQ: CLWT) is up 55% at $4.50. The Chinese water treatment company has been awarded two new contracts.

Towerstream Corp. (NASDAQ: TWER) is up nearly 42% at $3.69. The 4G wireless provider reported better-than-expected earnings after markets closed yesterday.

Aixtron SE (NASDAQ: AIXG) is up more than 18% at $131. The LED maker is getting a boost from an analyst’s upgrade. More coverage here.

Winnebago Industries Inc. (NYSE: WGO) is up about 16% at $10.32. The recreational vehicle maker missed estimates this morning, but reported a strong order backlog.

Coffee Holding Co. Inc. (NASDAQ: JVA) is up more than 15% at $13.73. The coffee wholesaler continues to attract buying on its strong earnings report last week.

Scholastic Corp. (NASDAQ: SCHL) is up more than 14% at $36.89 after posting a new 52-week high of $40.17 earlier today. The children’s media company raised its 2012 guidance.

Flamel Technologies SA (NASDAQ: FLML) is down nearly -23% at $6.18. The French-based biopharmaceutical company has acquired Eclat Pharmaceuticals and Eclat’s CEO will take over the combined company.

Verso Paper Corp. (NYSE: VRS) is down nearly -13% at $1.77. The paper firm is giving back last week’s gains as its tender offer had to be extended.

Eagle Bulk Shipping Inc. (NASDAQ: EGLE) is down more than -12% at $1.58. The dry bulk shipper reported a narrower-than-expected loss yesterday, but shipping companies still face a terrible year.

Vringo Inc. (AMEX: VRNG) is down more than -11% at $1.63. The social networking software company is merging with Innovate/Protect Inc. See the press release for details.

Stay tuned for Friday. Chicago Federal Reserve President Charles Evans is giving a speech. We have also noted the following events on the schedule (all times Eastern):

8:30 a.m. – Consumer price index
9:15 a.m. – Industrial production
9:55 a.m. – Reuters/University of Michigan consumer sentiment index

Paul Ausick

Filed under: Market Close Tagged: AIXG, AMCX, AXAS, CATO, CELG, CLWT, DLR, DNDN, E, EBAY, EGLE, FF, FLML, JVA, NSC, ROST, SCHL, TA, TWER, VRNG, VRS, WGO

Top Analyst Upgrades & Downgrades (AMD, AIXG, CELG, DNDN, DLR, EBAY, ICE, JOY, LVLT, NSC, RSH, BOX, VECO)

Administrator — Thu, 15 Mar 2012 12:27:39 +0000

These are some of this Thursday’s top analyst upgrades, downgrades, and initiations seen in Wall Street research calls.

Advanced Micro Devices, Inc. (NYSE: AMD) Raised to Buy at Jefferies.

Aixtron SE (NASDAQ: AIXG) Raised to Buy at Deutsche Bank.

Celgene Corporation (NASDAQ: CELG) Started as Buy at Stifel Nicolaus.

Dendreon Corporation (NASDAQ: DNDN) Started as Hold at Stifel Nicolaus.

Digital Realty Trust (NYSE: DLR) Cut to Hold at Jefferies.

eBay Inc. (NASDAQ: EBAY) Cut to Neutral at Credit Suisse.

IntercontinentalExchange, Inc. (NYSE: ICE) named Bull of the Day at Zacks.

Joy Global, Inc. (NYSE: JOY) Cut to Neutral at UBS.

Level 3 Communications, Inc. (NASDAQ: LVLT) Raised to Buy at BofA/ML.

Norfolk Southern Corporation (NYSE: NSC) Cut to Equal Weight at Barclays.

RadioShack Corporation (NYSE: RSH) named Bear of the Day at Zacks.

SeaCube Container Leasing Limited (NYSE: BOX) named as value stock of the day at Zacks.

Veeco Instruments Inc. (NASDAQ: VECO) Raised to Buy at Deutsche Bank.

JON C. OGG

Filed under: 24/7 Wall St. Wire, Analyst Calls Tagged: AIXG, AMD, BOX, CELG, DLR, DNDN, EBAY, ICE, JOY, LVLT, NSC, RSH, VECO

Top Analyst Upgrades & Downgrades (ALTR, AMSC, BIIB, CELG, COH, CSTR, COP, FSLR, GILD, HAIN, MA, RF, TRLG)

Administrator — Fri, 10 Feb 2012 13:23:06 +0000

These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms this Friday morning.

Altera Corporation (NASDAQ: ALTR) Cut to Underperform as Bear of the Day at Zacks.
American Superconductor Corporation (NASDAQ: AMSC) Raised to Buy at Citigroup.
Biogen Idec Inc. (NASDAQ: BIIB) Started as Overweight at Morgan Stanley.
Celgene Corporation (NASDAQ: CELG) Started as Overweight at Morgan Stanley.
Coach, Inc. (NYSE: COH) Started as Buy at Citigroup.
Coinstar, Inc. (NASDAQ: CSTR) named as Value stock of the day at Zacks.
ConocoPhillips (NYSE: COP) Raised to Buy at Deutsche Bank.
First Solar, Inc. (NASDAQ: FSLR) Cut to Neutral at Collins Stewart.
Gilead Sciences Inc. (NASDAQ: GILD) Started as Overweight at Barclays; Started as Overweight at Morgan Stanley.
Hain Celestial Group (NASDAQ: HAIN) maintained Outperform and named as Bull of the Day at Zacks.
MasterCard Inc. (NYSE: MA) Reiterated Buy and raised target to $450 at Argus.
Regions Financial Corporation (NYSE: RF) Raised to Outperform at Credit Suisse.
True Religion Apparel, Inc. (NASDAQ: TRLG) Cut to Hold at Brean Murray.

If you enjoyed the top analyst calls, you can sign up in the box below to join our morning email list to receive news directly in your inbox each morning. We include major analyst upgrades and downgrades, IPO and M&A news, special situation developments, observations on Warren Buffett and key market gurus, as well as special exclusive feature stories.

JON C. OGG

Filed under: 24/7 Wall St. Wire, Analyst Calls Tagged: ALTR, AMSC, BIIB, CELG, COH, COP, CSTR, FSLR, GILD, HAIN, MA, RF, TRLG

Top Analyst Upgrades & Downgrades (ALL, T, BBY, CELG, CLF, EQY, HIG, JCP, JNPR, KIM, PGR, SD, SYNA, UA, VPRT, ZOLL)

Administrator — Fri, 27 Jan 2012 13:27:24 +0000

These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms this Friday morning.

The Allstate Corporation (NYSE: ALL) Started as Outperform at William Blair.
AT&T Inc. (NYSE: T) Reinstated as Neutral with $30 price target at Credit Suisse.
Best Buy Co., Inc. (NYSE: BBY) Started as Outperform with $32 target at Credit Suisse.
Celgene Corporation (NASDAQ: CELG) Cut to Hold on Valuation at Argus.
Cliffs Natural Resources (NYSE: CLF) Cut to Neutral at Credit Suisse.
Equity One Inc. (NYSE: EQY) Cut to Sell at Citigroup.
Hartford Financial Services Group (NYSE: HIG) Cut to Neutral at JPMorgan.
J.C. Penney Company, Inc. (NYSE: JCP) Raised to Overweight at Piper Jaffray; Maintained as Buy but raised price target to $49 at Argus.
Juniper Networks Inc. (NYSE: JNPR) Cut to Market Perform at Morgan Keegan.
Kimco Realty Corporation (NYSE: KIM) Cut to Neutral at Citigroup.
The Progressive Corporation (NYSE: PGR) Started as Underperform at William Blair.
Sandridge Energy Inc. (NYSE: SD) Started as Buy at Citigroup.
Synaptics Inc. (NASDAQ: SYNA) Raised to Buy at Needham; Cut to Neutral at Stern Agee.
Under Armour, Inc. (NYSE: UA) Reiterated as Buy with $102 price target at Canaccord Genuity.
Vistaprint NV (NASDAQ: VPRT) Cut to Underperform as Bear of the Day at Zacks.
ZOLL Medical Corporation (NASDAQ: ZOLL) maintained Outperform as Bull of the Day at Zacks.

JON C. OGG

Filed under: 24/7 Wall St. Wire, Analyst Calls Tagged: ALL, BBY, CELG, CLF, EQY, HIG, JCP, JNPR, KIM, PGR, SD, SYNA, T, UA, VPRT, ZOLL

High-Premium Biotech M&A Continues (AMGN, CELG, MITI, IBB)

Administrator — Thu, 26 Jan 2012 22:08:49 +0000

Thursday brought yet more merger and acquisition news in the ongoing buyout trends in the biotech sector. Amgen Inc. (NASDAQ: AMGN) announced that it is going to acquire Micromet, Inc. (NASDAQ: MITI), a cancer drug maker that is German and American. Celgene Corporation (NASDAQ: CELG) announced that it was going to acquire an outfit called Avila Therapeutics, a developer of cancer drugs.

The Micromet deal is valued at $11.00 per share. This was a 33% premium to the prior close and shares closed up 32% at $10.94. The prior 52-week range was $4.13 to $8.90. Unfortunately for M&A arbitrage players, this deal offers no real upside in an arb-spread and it seems unlikely that a higher bid is coming based upon its share price never having gone above $11.00 today. That buyout is on the heels of a deal signed last year where Amgen agreed to an upfront payment for a discovery and development deal. Amgen is indicated around $69 after turning in 3% sales growth after the close.

Avila Therapeutics is a developer of covalent drugs in cancer and this $925 million buyout from Celgene is a cash and stock deal with $350 million of the total coming in cash. This company has AVL-292 as a inhibitor now in Phase I studies. Celgene shares are around $72.65 and are also with striking distance of a 52-week high ($75.11).

It is interesting that with two deals already having been announced in the last 24-hours that the iShares Nasdaq Biotechnology (NASDAQ: IBB) ETF was down by almost 1% at $114.71 on a day when there were two deals on the heels of another large premium acquisition this week.

JON C. OGG

Filed under: 24/7 Wall St. Wire, Biotech, Drug companies, Healthcare, Mergers and Buy Outs Tagged: AMGN, CELG, IBB, MITI

Tracking Dividends in Biotech: Who Follows Amgen in Payouts? (AMGN, PFE, MRK, BIIB, CELG, ALXN, CBST, PDLI, REGN, VRTX)

Administrator — Wed, 04 Jan 2012 13:01:10 +0000

For several years it has been the case that Amgen Inc. (NASDAQ: AMGN) was considered a biotech though it had at least some of the same problems of Big Pharma players like Pfizer Inc. (NYSE: PFE) and Merck & Co. (NYSE: MRK). The difference is that Amgen refused for ages to pay a dividend. 2011 marked a change in its dividend policy.

Amgen’s current dividend is 2.3%, which is rather high for a biotech stock. It also should be noted that the $64.00 price is above the stock’s old former rangebound levels of $50.00 to $60.00. Pfizer currently yields 3.7%, but that is about to rise to closer to 4%, and Merck yields about 4.50% after its dividend hike.

The question for 2012 is simple: Which biotech stocks will be among the second waves to initiate paying a dividend? By our count, these are the biotech outfits that might entertain following Amgen’s dividend path: Biogen Idec Inc. (NASDAQ: BIIB), Celgene Corporation (NASDAQ: CELG), Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN), Cubist Pharmaceuticals Inc. (NASDAQ: CBST), PDL BioPharma, Inc. (NASDAQ: PDLI), Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), and Vertex Pharmaceuticals Inc. (NASDAQ: VRTX).

We would have evaluated the chances of Gilead Sciences Inc. (NASDAQ: GILD) initiating a dividend, but this $11 billion proposed buyout of Pharmasset, Inc. (NASDAQ: VRUS) is likely to keep Gilead tied up for quite some time.

Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) is close to all-time highs above $70 and is now worth a whopping $13.2 billion. Estimates are $1.30 EPS for 2011 and $1.66 EPS for 2012, making this one have a much higher valuation while it is still rapidly growing. Some investors may expect that it could start paying out a dividend, but it is too soon by our take today, even with a $445 million balance of cash and liquidity with almost no long-term debt.

Biogen Idec Inc. (NASDAQ: BIIB) has estimates of $5.89 EPS in 2011 and $6.31 EPS in 2012. The company had only about $3 billion in cash and investments at the end of September versus a current market cap of about $27 billion. 2011 was the year that investors decided to give up on worrying about the very rare PML cases in TYSABRI, and that allowed Biogen shares to rise almost 60% in 2011. If Biogen decides to get off the no-dividend bandwagon soon, we would only look for an initial payout of $1.00 on an annualized basis for a while.

Celgene Corporation (NASDAQ: CELG) may still be too new of an earnings story to start expecting a dividend. The earnings estimates are $3.80 EPS in 2011 and $4.51 EPS in 2012. With almost $2.6 billion in cash and investments, its market cap is larger than Biogen’s at $30 billion.

Cubist Pharmaceuticals Inc. (NASDAQ: CBST) managed an incredible breakout year as its drugs treat hospital-borne infections, with nearly a 100% share price gain in 2011. The market cap is now about $2.45 billion, and it had nearly $1 billion in cash and liquidity before a recent $221 million acquisition versus about $450 million in long-term debt. Cubist probably could start to pay a dividend if it wants to, but the company has decided to be an acquirer rather than hoarding cash or going defensive. Chances are that it may need to hold on to its cash while it absorbs Adolor and anything else it is considering.

PDL BioPharma, Inc. (NASDAQ: PDLI) has been a dividend payer from its patent royalties, but some payments have been one-time payments until its most recent $0.15 payout for each of the past four quarters. The company also recently forecast a 5% revenue drop and investors are already braced for lower royalty payments. The company recently lost its CFO after only about three years on the job and we really do not like to see CFOs leave biohealth companies. Estimates are $1.18 EPS for 2011 and $1.38 EPS in 2012, but it has about $225 million in cash and liquidity versus a market cap of $867 million. The company may just stick with its current payout structure’s high yield as is until (or if) it can secure another large patent license.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is worth some $5.1 billion or so in market capitalization and is fresh off the news that it settled with Genentech over U.S. opthalmic sales of the eye drug EYLEA with a patent case still brewing, but with Regeneron agreeing to pay out $60 million if sales reach $400 million and it will pay royalties out as well. With cash and liquidity of near $500 million at then end of September we think it is a bit premature to ask this one to start shelling out its cash to shareholders yet, considering it is still expected to have a wide loss in 2012.

Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) is so far off of highs now that it seems unlikely investors are expecting much on the dividend front. The company is back on the path of growth after some changes and stumbles, and now its market cap is almost $7 billion. With this one it just feels too soon to expect any dividends in reality. We could analyze all we want, but its new revenue growth is challenged by a cash balance of just over $800 million versus $400 million in long-term debt. What is interesting is that Vertex’s $0.30 EPS expected for 2011 is expected to be $4.55 EPS in 2012. It had a loss of $3.77 EPS in 2010. Maybe after another year or so we can evaluate its future dividend strategy.

After reviewing the great biotech sector’s larger components, it sure does not sound like many other than Biogen Idec Inc. (NASDAQ: BIIB) are really new prime-time dividend candidates for 2012, other than the high payout of PDL BioPharma, Inc. (NASDAQ: PDLI).

JON C. OGG

Filed under: Biotech, Dividend, Drug companies, Healthcare, Shareholder Issues Tagged: ALXN, AMGN, BIIB, CBST, CELG, MRK, PDLI, PFE, REGN, VRTX, VRUS

Top Analyst Upgrades & Downgrades (ALB, AMZN, BBBY, BP, CELG, CHRW, FSLR, HAIN, HGSI, MMM, MIND, NYT, SKS, TLM, YGE, YOKU)

Administrator — Wed, 26 Oct 2011 12:06:12 +0000

These are some of this Wednesday’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this morning.

Albemarle Corporation (NYSE: ALB) Raised to Neutral at BofA/ML.
Amazon.com Inc. (NASDAQ: AMZN) Cut estimates and target to $200 at Credit Suisse; maintained Buy at BofA/ML.
Bed Bath & Beyond Inc. (NASDAQ: BBBY) Reiterated Buy and raised target to $70 at Argus.
BP PLC (NYSE: BP) Raised estimates at BofA/ML.
Celgene Corporation (NASDAQ: CELG) Raised to Outperform as Bull of the Day at Zacks.
C.H. Robinson Worldwide Inc. (NASDAQ: CHRW) Cut to Neutral at BofA/ML.
First Solar Inc. (NASDAQ: FSLR) Cut to Hold at Kaufman; Cut to Hold at Jefferies; Cut to Sell at S&P Capital IQ (late Tuesday).
The Hain Celestial Group, Inc. (NASDAQ: HAIN) Raised to Hold at S&P Capital IQ (late Tuesday).
Human Genome Sciences Inc. (NASDAQ: HGSI) Cut to Hold at Brean Murray.
3M Co. (NYSE: MMM) Cut to Market Perform at William Blair.
Mitcham Industries, Inc. (NASDAQ: MIND) named the Value Stock of the Day at Zacks.
The New York Times Company (NYSE: NYT) Cut to Neutral at Citigroup.
Saks, Inc. (NYSE: SKS) named Aggressive Growth stock of the day at Zacks.
Talisman Energy (NYSE: TLM) Cut to Underperform as Bear of the Day at Zacks.
Yingli Green Energy Holding Co. Ltd. (NYSE: YGE) Cu to Neutral at Collins Stewart.
Youku.com Inc. (NYSE: YOKU) Cut to Neutral at Susquehanna.

JON C. OGG

Filed under: Analyst Calls Tagged: ALB, AMZN, BBBY, BP, CELG, CHRW, FSLR, HAIN, HGSI, MIND, MMM, NYT, SKS, TLM, YGE, YOKU

Top Analyst Upgrades & Downgrades (AMGN, ARIA, BIIB, CELG, LFC, CSCO, DRI, FIO, GPN, HUM, LEN, MSI, TLB, TZOO)

Administrator — Thu, 08 Sep 2011 12:23:27 +0000

These are some of this Thursday’s top analyst upgrades, downgrades, and initiations seen having an impact from Wall Street research calls.

Amgen Inc. (NASDAQ: AMGN) Started as Outperform at BMO.
Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) Started as Outperform at BMO.
Biogen Idec Inc. (NASDAQ: BIIB) Started as Underperform at BMO.
Celgene Corporation (NASDAQ: CELG) Started as Outperform at BMO.
China Life Insurance (NYSE: LFC) Started as Underperform as Bear of the Day at Zacks.
Cisco Systems, Inc. (NASDAQ: CSCO) Raised to Buy at Auriga.
Darden Restaurants, Inc. (NYSE: DRI) Raised to Outperform at Wells Fargo.
Fusion-io Inc. (NYSE: FIO) Started as Sell at Merriman.
Global Payments Inc. (NYSE: GPN) Started as Buy at Citigroup.
Humana Inc. (NYSE: HUM) named value stock of the day at Zacks.
Lennar Corporation (NYSE: LEN) Started as Outperform at FBR.
Motorola Solutions, Inc. (NYSE: MSI) Raised to Outperform as Bull of the Day at Zacks.
The Talbots Inc. (NYSE: TLB) Raised to Neutral at Piper Jaffray.
Travelzoo Inc. (NASDAQ: TZOO) Cut to Market Perform at Morgan Keegan.

JON C. OGG

Filed under: Analyst Calls Tagged: AMGN, ARIA, BIIB, CELG, CSCO, DRI, FIO, GPN, HUM, LEN, LFC, MSI, TLB, TZOO

August’s New Massive Stock Buybacks… Over $30 Billion (LOW, CVS, CELG, COV, INTU, DISCA, HRS, LMT, RSG, LOW, ABC, MXIM, ANR, AVT, JAH, LUV, STJ, ECL, IPG, FRX, ACE, CLF, CTSH, KBR, NWL, VRX, AKAM, AOL, DLB, URBN, ACM, CHTR, MYGN, PFG, HSIC)

Administrator — Wed, 31 Aug 2011 19:00:52 +0000

The pace of stock buyback announcements in the month of August was almost unbelievable. The pace was stronger at the start of the month when earnings were still coming in droves, but the number of newly announced buyback plans and the extended or expanded buyback plans remained high throughout the entire month. Many companies announce share buybacks and never spend much on the actual plan. Today, these companies are by and large actually living up to their promises. These are The August Buyback Kings….

We would normally group these alphabetically, but not today. We grouped these in order of size and then we used an alphabetic order when it came to the same size of a buyback announcement. The first group is the billions of dollars.

We then grouped the stocks by size again from the under $1 billion down to $500 million, and then we grouped the buybacks of under $500 million down to $200 million. Usually we would cut the list off at buybacks of the $100 million and higher but the list was already too big so we cut the Buyback Kings off at $200 million for August. Lastly, we have a chart at the very end tallying it all up…. Some $28.7 billion for just the $200 million and higher in new or expanded buyback announcements. There were literally dozens of other buybacks that were closer to the $100 million mark and many more that were less than that.

The $1 billion and higher alone which were announced in August were as follows: Lowe’s Companies, Inc. (NYSE: LOW); CVS Caremark Corporation (NYSE: CVS); Celgene Corporation (NASDAQ: CELG); Covidien plc (NYSE: COV); Intuit Inc. (NASDAQ: INTU); Discovery Communications, Inc. (NASDAQ: DISCA); Harris Corporation (NYSE: HRS); and Lockheed Martin Corporation (NYSE: LMT).

Filed under: Dividend, Shareholder Issues, Stock Buybacks Tagged: ABC, ACE, ACM, AKAM, ANR, AOL, AVT, CELG, CHTR, CLF, COV, CSCO, CTSH, CVS, CVX, DISCA, DLB, ECL, FRX, HRS, INTU, IPG, JAH, KBR, LMT, LOW, LUV, MXIM, MYGN, NWL, NWSA, PFG, RSG, STJ, URBN, VRX, XOM